Войти в систему Зарегистрироваться бесплатно

Ayala Pharmaceuticals P/E

Что обозначает P/E в Ayala Pharmaceuticals?

P/E Ayala Pharmaceuticals Inc. является N/A

Какое определение для P/E ?



Соотношение цены и прибыли является отношением цены акций компании к прибыли компании на акцию, рассчитанным за последние 12 месяцев.

The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.

P/E компаний в Health Care сектор на NASDAQ по сравнению с Ayala Pharmaceuticals

Что делает Ayala Pharmaceuticals?

advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.

Компании с p/e похож на Ayala Pharmaceuticals